1. AMBER 2020, Case, D.A., Belfon, K., Ben-Shalom, I.Y., Brozell, S.R., Cerutti, D.S., T.E. Cheatham, I., V.W.D. Cruzeiro, Darden, T.A., Duke, R.E., Giambasu, G., Gilson, M.K., Gohlke, H., A.W. Goetz, R.H., Izadi, S., K. Kasavajhala, Kovalenko, A., Krasny, R., Kurtzman, T., Lee, T.S., LeGrand, S., Li, P., Lin, C., Liu, J., Luchko, T., R. Luo, Man, V., Merz, K.M., Miao, Y., Mikhailovskii, O., Monard, G., Nguyen, H., Onufriev, A., Pan, F., S. Pantano, Qi, R., Roe, D.R., Roitberg, A., Sagui, C., Schott-Verdugo, S., Shen, J., Simmerling, C.L., Skrynnikov, N., Smith, J., Swails, J., Walker, R.C., Wang, J., Wilson, L., Wolf, R.M., Wu, X., York, D.M.Kollman, P.A., 2020. University of California, San Francisco.
2. Trends in kinase drug discovery: targets, indications and inhibitor design;Attwood;Nat. Rev. Drug Discov.,2021
3. Activation of tyrosine kinases by mutation of the gatekeeper threonine;Azam;Nat. Struct. Mol. Biol.,2008
4. ASK1 and its role in cardiovascular and other disorders: available treatments and future prospects;Baig;Expert Rev. Proteom.,2019
5. Small molecules, big impact: 20 years of targeted therapy in oncology;Bedard;Lancet,2020